Diabetes Mellitus Ii clinical trials

Explore recruiting diabetes mellitus ii clinical trials.

Recruiting diabetes mellitus ii studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetes Mellitus Ii trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective study to assess with Continuous Glucose Monitoring (CGM) the efficacy and safety of switching to insulin glargine 300 U/ml from insulin glargine 100 U/ml in Type 2 Diabetes (T2DM) patients with renal impairment

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Diabetes Mellitus Ii trials by city

Diabetes Mellitus Ii in Toronto Diabetes Mellitus Ii in Vancouver Diabetes Mellitus Ii in Montreal Diabetes Mellitus Ii in Calgary Diabetes Mellitus Ii in Edmonton Diabetes Mellitus Ii in Ottawa Diabetes Mellitus Ii in Winnipeg Diabetes Mellitus Ii in Quebec City Diabetes Mellitus Ii in Hamilton Diabetes Mellitus Ii in Kitchener Diabetes Mellitus Ii in London Diabetes Mellitus Ii in Halifax Diabetes Mellitus Ii in New York Diabetes Mellitus Ii in Los Angeles Diabetes Mellitus Ii in Chicago Diabetes Mellitus Ii in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease